Statement re Arysta LifeScience

RNS Number : 7469R

Wilmcote Holdings PLC

18 June 2018

 

18^th June 2018                    This announcement contains inside information 

Wilmcote Holdings plc

Statement re Arysta LifeScience

Wilmcote Holdings plc ('Wilmcote') announces that it is no longer in discussions with Platform Speciality Products Corporation regarding a potential acquisition of its Agricultural Solutions segment, Arysta LifeScience. In line with the Company's mandate to pursue acquisition opportunities, the Company has incurred material third party expenses in connection with this opportunity.

CEO Adrian Whitfield said "We note Arysta LifeScience's announcement today that it is in exclusive discussions with another party. Arysta LifeScience offers an attractive acquisition opportunity for Wilmcote and we will monitor developments with continued interest."

Wilmcote's ordinary shares will recommence trading with immediate effect.

-ENDS-

Teneo (Financial PR)                                                                               Tel: [phone]
Charles Armitstead/ Rosie Oddy               

Numis Securities Limited (Nominated Adviser and Broker)         Tel: [phone]

Ross Mitchinson

Jamie Lillywhite

James Taylor

Jamie Loughborough

Adrian Whitfield is Chief Executive Officer of Wilmcote Holdings plc, which has its UK establishment address at 11 Buckingham Street, London WC2N 6DF and has the LEI number 2138004EUUU11OVHZW75.

 

END

 

 

STRFPMJTMBTBBAP